ATC code M: Musculo-skeletal system |
---|
|
Other ATC codes |
ATC code M05 Drugs for treatment of bone diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup M05 is part of the anatomical group M Musculo-skeletal system.
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM05.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
M05B Drugs affecting bone structure and mineralization
M05BA Bisphosphonates
- M05BA01 Etidronic acid
- M05BA02 Clodronic acid
- M05BA03 Pamidronic acid
- M05BA04 Alendronic acid
- M05BA05 Tiludronic acid
- M05BA06 Ibandronic acid
- M05BA07 Risedronic acid
- M05BA08 Zoledronic acid
M05BB Bisphosphonates, combinations
- M05BB01 Etidronic acid and calcium, sequential
- M05BB02 Risedronic acid and calcium, sequential
- M05BB03 Alendronic acid and colecalciferol
- M05BB04 Risedronic acid, calcium and colecalciferol, sequential
- M05BB05 Alendronic acid, calcium and colecalciferol, sequential
- M05BB06 Alendronic acid and alfacalcidol, sequential
- M05BB07 Risedronic acid and colecalciferol
- M05BB08 Zoledronic acid, calcium and colecalciferol, sequential
- M05BB09 Ibandronic acid and colecalciferol
M05BC Bone morphogenetic proteins
- M05BC01 Dibotermin alfa
- M05BC02 Eptotermin alfa
M05BX Other drugs affecting bone structure and mineralization
- M05BX01 Ipriflavone
- M05BX02 Aluminium chlorohydrate
- M05BX03 Strontium ranelate
- M05BX04 Denosumab
- M05BX05 Burosumab
- M05BX06 Romosozumab
- M05BX07 Vosoritide
- M05BX08 Menatetrenone
- M05BX53 Strontium ranelate and colecalciferol
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code M05". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QM05". WHO Collaborating Centre for Drug Statistics Methodology.
Drugs for treatment of bone diseases (M05) | |
---|---|
Bisphosphonates | |
Bone morphogenetic proteins | |
Other |
|